AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,667 | -99.9% | 58 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $1,991,000 | -48.6% | 130,468 | -36.9% | 0.00% | -40.0% |
| Q1 2018 | $3,874,000 | -12.2% | 206,601 | -9.9% | 0.01% | -16.7% |
| Q4 2017 | $4,411,000 | +16.3% | 229,277 | +8.1% | 0.01% | +20.0% |
| Q3 2017 | $3,792,000 | +8.6% | 212,183 | +8.5% | 0.01% | 0.0% |
| Q2 2017 | $3,492,000 | +59.5% | 195,547 | +29.5% | 0.01% | +25.0% |
| Q1 2017 | $2,190,000 | +19.7% | 151,055 | +52.1% | 0.00% | +33.3% |
| Q4 2016 | $1,830,000 | -51.2% | 99,324 | -49.7% | 0.00% | -57.1% |
| Q3 2016 | $3,750,000 | -11.6% | 197,658 | -21.0% | 0.01% | -12.5% |
| Q2 2016 | $4,241,000 | +20.6% | 250,331 | -9.5% | 0.01% | +14.3% |
| Q1 2016 | $3,517,000 | -10.6% | 276,472 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $3,934,000 | +45.2% | 276,472 | +19.2% | 0.01% | +33.3% |
| Q3 2015 | $2,710,000 | – | 231,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MQS Management LLC | 10,935 | $255,000 | 0.41% |
| GLOBEFLEX CAPITAL L P | 144,692 | $3,370,000 | 0.34% |
| CORNERCAP INVESTMENT COUNSEL INC | 58,975 | $1,374,000 | 0.20% |
| Factorial Partners, LLC | 10,900 | $254,000 | 0.17% |
| FEDERATED HERMES, INC. | 3,464,335 | $80,684,000 | 0.15% |
| Campbell & CO Investment Adviser LLC | 14,800 | $345,000 | 0.12% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 611,462 | $14,241,000 | 0.08% |
| Summit Global Investments | 45,900 | $1,069,000 | 0.07% |
| RENAISSANCE GROUP LLC | 63,559 | $1,480,000 | 0.06% |
| PDT Partners, LLC | 33,459 | $779,000 | 0.06% |